NEW YORK (GenomeWeb News) – Direct-to-consumer genetic testing firm 23andMe announced several new appointments to its executive team, including Christine Castro as VP of communications, Neil Rothstein as VP of marketing, and Jonathan Ward as VP of strategic alliances.

Before joining 23andMe, Castro was VP of corporate relations at Genentech, chief communications officer for Yahoo!, and VP of corporate communications at The Walt Disney Company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.